Health Headlines 6/6/06
New Study Re-evaluates Cardiovascular Risks Of Non-steroidal Anti-inflammatory Drugs (NSAIDS) ~ Click here.
Combination Therapy Shows Promising Results In Patients With Advanced Lung Cancer ~ Click here.
Study Evaluates Benefits And Risks Of Tamoxifen And Raloxifene For Reducing Risk Of Breast Cancer ~ Click here.
Researchers Announce New Predictor For Lung Cancer Treatment And Survival ~ Click here.
Tumor Response May Not Be Best Measure Of Efficacy In Non-small Cell Lung Cancer Treatment ~ Click here.
Markey Cancer Center Receives FDA Approval To Test Novel Cancer Drug, University Of Kentucky ~ Click here.
Rage Disorder Affects 7.3 Per Cent Of US Adults ~ Click here.
Combination Therapy Shows Promising Results In Patients With Advanced Lung Cancer ~ Click here.
Study Evaluates Benefits And Risks Of Tamoxifen And Raloxifene For Reducing Risk Of Breast Cancer ~ Click here.
Researchers Announce New Predictor For Lung Cancer Treatment And Survival ~ Click here.
Tumor Response May Not Be Best Measure Of Efficacy In Non-small Cell Lung Cancer Treatment ~ Click here.
Markey Cancer Center Receives FDA Approval To Test Novel Cancer Drug, University Of Kentucky ~ Click here.
Rage Disorder Affects 7.3 Per Cent Of US Adults ~ Click here.
0 Comments:
Post a Comment
<< Home